|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





From the * Orthopaedic Hospital, Lovran, Croatia, the
Department of Orthopaedic Surgery, School of Medicine, University of Zagreb, Zagreb, Croatia, the
Department of Anatomy, School of Medicine, University of Rijeka, Rijeka, Croatia,
Clinical Institute of Laboratory Diagnosis, Clinical Hospital Centre, Zagreb, Croatia, and the || Department of Anatomy, School of Medicine, University of Zagreb, Zagreb, Croatia
¶ Address correspondence to Slobodan Vukicevic, MD, PhD, Department of Anatomy, School of Medicine, University of Zagreb, Salata 11, 10000 Zagreb, Croatia (e-mail: vukicev{at}mef.hr).
Background: Bone morphogenetic proteins induce new bone both in patients with bone defects and at extraskeletal sites in animals. After anterior cruciate ligament rupture, tendon graft fixation into a bone tunnel is a widely used method for anterior cruciate ligament reconstruction.
Hypothesis: Bone morphogenetic protein7 applied to the bone-tendon interface enables better integration of a free tendon graft into the surrounding bone.
Study Design: Controlled laboratory study.
Methods: The anterior cruciate ligament was reconstructed using a free tendon graft in the right rear knees of 30 one-year-old male sheep. Recombinant human bone morphogenetic protein7 (25 µg) was applied randomly to the bone-tendon interface in 15 animals, and a vehicle was applied in 15 control animals. At 3 weeks, 10 animals from each group were sacrificed, and the remaining sheep were sacrificed at 6 weeks after surgery. Subsequently, histologic analysis and mechanical testing were performed. In another group of 20 sheep, the same procedure was used and mechanical testing was performed after 3 weeks.
Results: More new bone was formed at the bone-tendon interface in the knees treated with bone morphogenetic protein7 as compared histologically with similar areas in control animals, creating areas of dense trabecular network with significantly greater invasion of the tendon fibrous tissue into the bone marrow space. Mechanical testing showed greater strain resistance to force (368 N) in the knees treated with bone morphogenetic protein7 than in control specimens (214 N). There was no difference between mechanical testing of samples from 3 and 6 weeks after surgery.
Conclusion: Bone morphogenetic protein7 promotes complete tendon graft integration into the newly formed surrounding trabecular bone in the reconstruction of the anterior cruciate ligament.
Clinical Relevance: Bone morphogenetic protein7 in tendon graft integration might be successfully used in reconstructive surgery of ligaments.
Key Words: bone morphogenetic protein7 (BMP-7) osteogenic protein1 (OP-1) anterior cruciate ligament (ACL) ligament reconstruction
This article has been cited by other articles:
![]() |
R. Hayashi, E. Kondo, H. Tohyama, T. Saito, and K. Yasuda In vivo local administration of osteogenic protein-1 increases structural properties of the overstretched anterior cruciate ligament with partial midsubstance laceration: A BIOMECHANICAL STUDY IN RABBITS J Bone Joint Surg Br, October 1, 2008; 90-B(10): 1392 - 1400. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Steiner, M. M. Murray, and S. A. Rodeo Strategies to Improve Anterior Cruciate Ligament Healing and Graft Placement Am. J. Sports Med., January 1, 2008; 36(1): 176 - 189. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |